EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Demographic Refinement and Atrial Fibrillation Type in Stroke Risk Stratification beyond CHA 2 DS 2 VASc

Karim M Mahawish, Rita V Krishnamurthi, Suzanne Barker-Collo, Annamarei Ranta, Derrick Bennett, Irene Suilen Zeng, Valery Feigin, Harvey White

Cerebrovascular Diseases Extra · 02.07.2026 · 16 (1) · 206-211

DOI: 10.1159/000553393 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cerebrovascular Diseases Extra, online erschienen am 02.07.2026. Verfasst von Karim M Mahawish und 7 weiteren Autor:innen. Beteiligte Einrichtung: Stroke Department, Te Whatu Ora Counties Health, Auckland, New Zealand, tyj9598@autuni.ac.nz. Hauptthemen laut MEDLINE: Atrial Fibrillation, Ischemic Attack, Transient, Ischemic Stroke, Decision Support Techniques. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The CHA2DS2 VASc score is widely used for stroke risk stratification in atrial fibrillation (AF). Efforts to improve prediction using demographic refinements have uncertain incremental value, particularly in multi-ethnic populations. We evaluated whether demographic modification or AF type provides additional discriminatory value.

Methods

We conducted a retrospective nested case-control study of patients with AF diagnosed prior to the fifth Auckland Regional Community Stroke Study (September 2020–August 2021). Cases with ischaemic stroke or transient ischaemic attack were identified from this population-based registry with central adjudication. Controls were randomly selected from the National Minimum Dataset, stratified by ethnicity. Predictors included CHA2DS2 VASc components, demographic refinements (alternative age transformations, ethnicity, and exclusion of sex), and AF type. The primary baseline model was a multivariable logistic regression model using standard CHA2DS2 VASc predictors as covariates. The traditional point-based CHA2DS2 VASc score was evaluated separately for comparison. Discrimination was assessed using the area under the receiver operating characteristic curve (AUC).

Results

The study included 1,908 patients (300 cases). A logistic regression model using standard CHA2DS2 VASc predictors demonstrated moderate discrimination {AUC 0.68 (95% confidence interval [CI]: 0.65–0.71)}. The traditional point-based CHA2DS2 VASc score showed lower discrimination (AUC 0.63 [95% CI: 0.60–0.66]; ΔAUC +0.05; p = 0.0003). Demographic refinements did not improve discrimination (ΔAUC ≤ 0.01). Addition of AF type modestly increased discrimination (AUC 0.71; ΔAUC +0.03; p = 0.015), with greater improvement in non-anticoagulated patients (ΔAUC +0.05).

Conclusion

Demographic refinements, including ethnicity, provide limited incremental value beyond CHA2DS2 VASc, whereas AF type offers a modest discriminatory signal. This finding is hypothesis-generating and requires external validation before clinical implementation is considered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationIschemic Attack, TransientIschemic StrokeDecision Support TechniquesStrokeHumansFemaleRisk AssessmentRetrospective StudiesRisk FactorsAgedMalePredictive Value of TestsAged, 80 and overMiddle AgedNew ZealandRegistriesPrognosisCase-Control StudiesAge Factors

Stichwörter der Autor:innen

Atrial fibrillationIschaemic strokeRisk predictionTransient ischaemic attack

Autor:innen und Institutionen

  • Stroke Department, Te Whatu Ora Counties Health, Auckland, New Zealand, tyj9598@autuni.ac.nz.
  • National Institute for Stroke and Applied Neurosciences, School of Community and Public Health, Auckland University of Technology, Auckland, New Zealand, tyj9598@autuni.ac.nz.
  • National Institute for Stroke and Applied Neurosciences, School of Community and Public Health, Auckland University of Technology, Auckland, New Zealand.
  • Clinical Training Programme, School of Psychology, The University of Auckland/Waipapa Taumata Rau, Auckland, New Zealand.
  • Medicine, University of Otago - Wellington, Wellington, New Zealand.
  • Neurology, Te Whatu Ora Health New Zealand Capital Coast and Hutt Valley, Wellington, New Zealand.

Zitieren

APA

Mahawish, K. M., Krishnamurthi, R. V., Barker-Collo, S., Ranta, A., Bennett, D., Zeng, I. S., Feigin, V., & White, H. (2026). Demographic Refinement and Atrial Fibrillation Type in Stroke Risk Stratification beyond CHA 2 DS 2 VASc. Cerebrovascular Diseases Extra, 16(1), 206-211. https://doi.org/10.1159/000553393

Vancouver

Mahawish KM, Krishnamurthi RV, Barker-Collo S, Ranta A, Bennett D, Zeng IS, et al. Demographic Refinement and Atrial Fibrillation Type in Stroke Risk Stratification beyond CHA 2 DS 2 VASc. Cerebrovascular Diseases Extra. 2026;16(1):206-211. doi:10.1159/000553393

BibTeX
@article{Mahawish2026,
  author = {Mahawish, Karim M and Krishnamurthi, Rita V and Barker-Collo, Suzanne and Ranta, Annamarei and Bennett, Derrick and Zeng, Irene Suilen and Feigin, Valery and White, Harvey},
  title = {Demographic Refinement and Atrial Fibrillation Type in Stroke Risk Stratification beyond CHA 2 DS 2 VASc},
  journal = {Cerebrovascular Diseases Extra},
  year = {2026},
  volume = {16},
  number = {1},
  pages = {206--211},
  doi = {10.1159/000553393}
}
Kostenlos starten →